Authors: Awan, T Forloni, G Ragg, E Iussich, S Rossi, G Colombo, L Girola, L Massignan, T Bugiani, O Salmona, M Tagliavini, F

Citation: T. Awan et al., Therapeutic approaches to prion diseases: In vitro studies with tetracycline compounds, ALZHEIMER'S DISEASE, 2001, pp. 809-820

Authors: Puoti, G Rossi, G Giaccone, G Awan, T Lievens, PMJ Defanti, CA Tagliavini, F Bugiani, O

Citation: G. Puoti et al., Polymorphism at codon 129 of PRNP, affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation, ANN NEUROL, 48(2), 2000, pp. 269-270

Authors: Zerr, I Pocchiari, M Collins, S Brandel, JP Cuesta, JD Knight, RSG Bernheimer, H Cardone, F Delasnerie-Laupretre, N Corrales, NC Ladogana, A Bodemer, M Fletcher, A Awan, T Bremon, AR Budka, H Laplanche, JL Will, RG Poser, S

Citation: I. Zerr et al., Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease, NEUROLOGY, 55(6), 2000, pp. 811-815

Authors: Tagliavini, F Forloni, G Colombo, L Rossi, G Girola, L Canciani, B Angeretti, N Giampaolo, L Peressini, E Awan, T De Gioia, L Ragg, E Bugiani, O Salmona, M

Citation: F. Tagliavini et al., Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro, J MOL BIOL, 300(5), 2000, pp. 1309-1322

Authors: Salmona, M Malesani, P De Gioia, L Gorla, S Bruschi, M Molinari, A Della Vedova, F Pedrotti, B Marrari, MA Awan, T Bugiani, O Forloni, G Tagliavini, F

Citation: M. Salmona et al., Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126, BIOCHEM J, 342, 1999, pp. 207-214